Roza Shakhidova

Roza Shakhidova is an accomplished professional in the field of Market Access, currently serving as the Head of Market Access for Abbott’s VEROPHARM since June 2020. Previous roles include leadership positions at the American Eurasian Cancer Alliance, Roche, and Boehringer Ingelheim, where significant contributions included establishing relationships with governmental bodies, developing market access strategies, and addressing reimbursement challenges across various therapeutic areas. Shakhidova began a career in market access and sales at GSK, managing government affairs and implementing successful programs to increase market share. With a Master of Public Health and a medical degree from the First Moscow State Medical University, Shakhidova combines clinical knowledge with expertise in healthcare management.